https://investors.pepgen.com/news-releases/news-release-details/pepgen-announces-first-participant-dosed-phase-1-clinical-trial
A year ago PepGen raised over $108 million
For a phase 1 trial in DMD
The beauty of raising more money than wanted is that PepGen can start another trial in another indication
They have increased their staff from 20 to 40…
Rival to Sarepta
Will their trial be a success ?
IMO; No
- Forums
- ASX - By Stock
- PER
- For General Information
For General Information, page-1050
- There are more pages in this discussion • 2,477 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.41M |
Open | High | Low | Value | Volume |
7.9¢ | 7.9¢ | 7.6¢ | $26.62K | 343.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 113467 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.7¢ | 98248 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 113467 | 0.075 |
1 | 200000 | 0.072 |
1 | 20000 | 0.071 |
8 | 533632 | 0.070 |
1 | 134681 | 0.069 |
Price($) | Vol. | No. |
---|---|---|
0.077 | 98248 | 1 |
0.080 | 48600 | 2 |
0.081 | 120000 | 1 |
0.083 | 206000 | 2 |
0.085 | 250000 | 2 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
7.7¢ |
  |
Change
0.000 ( 1.28 %) |
|||
Open | High | Low | Volume | ||
7.9¢ | 7.9¢ | 7.7¢ | 14800 | ||
Last updated 15.52pm 06/05/2024 ? |
Featured News
PER (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online